Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.
Brian H West, Nabil Noureddin, Yakov Mamzhi...
https://pubmed.ncbi.nlm.nih.gov/29636424/Actively Recruiting
Led by Azienda Usl di Bologna · Updated on 2026-02-11
240
Participants Needed
1
Research Sites
153 weeks
Total Duration
Researchers are exploring the relationship between patent foramen ovale PFO and migraine with aura MA in adults diagnosed with MA according to recognized criteria. This observational study aims to understand genetic differences, especially in the NOTCH3 gene and other related genes, between patients with and without PFO, and to investigate how these differences may relate to vascular and platelet function. The study seeks to provide insights into the biological mechanisms linking PFO and MA, which may influence future prevention and treatment strategies. Participants are classified into two groups those with MA and PFO and those with MA without PFO. Each participant undergoes a single study visit including a detailed clinical and demographic assessment, neurosonological tests such as continuous Doppler monitoring for microembolic signals, cerebrovascular reactivity tests using breath-hold and hyperventilation, and contrast-enhanced shunt detection using agitated saline. Blood samples are collected for whole-exome sequencing focusing on selected genes and for platelet aggregation studies. During the visit, data on migraine characteristics and brain MRI findings are gathered when available. The study measures genetic variants, microembolic signals, cerebrovascular reactivity, cerebral autoregulation, and platelet function to analyze differences between groups. The study plans to enroll 240 adult participants over 36 months, aiming to clarify the biological differences between those with and without PFO and MA.
CONDITIONS
Neurogenetic And Hemodynamic Of Migraine Aura And Pfo
M
Matteo Paolucci
A
Andrea Zini
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Azienda Usl di Bologna
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo a single study visit involving neurosonological assessments including continuous transcranial Doppler monitoring, cerebrovascular reactivity testing, dynamic cerebral autoregulation evaluation, and contrast-enhanced shunt study using agitated saline. Blood samples are collected for genetic analysis and platelet function testing.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Brian H West, Nabil Noureddin, Yakov Mamzhi...
https://pubmed.ncbi.nlm.nih.gov/29636424/Xianming Hu, Yingchun Zhou, Hongyang Zhao...
https://pubmed.ncbi.nlm.nih.gov/27785579/Matteo Paolucci, Chiara Vincenzi, Michele Romoli...
https://pubmed.ncbi.nlm.nih.gov/34946902/R B Lipton, A I Scher, K Kolodner...
https://pubmed.ncbi.nlm.nih.gov/11914403/Graeme C Elliott, Rockesh Gurtu, Charles McCollum...
https://pubmed.ncbi.nlm.nih.gov/25215881/Hendrikus J A van Os, Inge A Mulder, Alexander Broersen...
https://pubmed.ncbi.nlm.nih.gov/28526767/Daniela Trabattoni, Marta Brambilla, Paola Canzano...
https://pubmed.ncbi.nlm.nih.gov/35818509/Matteo Paolucci, Claudia Altamura, Fabrizio Vernieri
https://pubmed.ncbi.nlm.nih.gov/33835736/Xinyi Li, Lingling Xie, Jin Dai...
https://pubmed.ncbi.nlm.nih.gov/38808331/Julie W Rutten, Hans G Dauwerse, Gido Gravesteijn...
https://pubmed.ncbi.nlm.nih.gov/27844030/Azienda Usl di Bologna
Lead Sponsor